| |
| |
|
| Insider
Information: |
Gottlieb Scott |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
48,372 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$909,455 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,372 |
|
|
| Total
Value |
$909,455 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -15.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CombiMatrix Corp |
CBMX |
Director |
2016-05-09 |
4,804 |
2009-05-28 |
0 |
Premium* |
|
|
Molecular Insight Pharmaceutical... |
MIPI |
Director |
2009-05-29 |
4,000 |
2009-05-29 |
0 |
Premium* |
|
|
Afh Acquisition Iii, Inc. |
|
Director |
2013-07-22 |
25,000 |
2013-07-22 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Director |
2023-12-15 |
9,000 |
2019-08-23 |
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2023-12-29 |
5,568 |
2020-02-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ILMN |
Illumina Inc |
Director |
• • – |
2023-12-29 |
4 |
A |
$113.48 |
$24,966 |
D/D |
220 |
5,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
Director |
• • – |
2023-12-15 |
4 |
B |
$26.47 |
$79,401 |
D/D |
3,000 |
9,000 |
2.39 |
% |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2023-09-29 |
4 |
A |
$166.74 |
$23,677 |
D/D |
142 |
5,348 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2023-06-30 |
4 |
A |
$205.79 |
$21,196 |
D/D |
103 |
5,206 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,532 |
5,103 |
0 |
- |
|
| PFE |
Pfizer Inc |
Director |
• • – |
2023-05-08 |
4 |
B |
$38.58 |
$38,580 |
D/D |
1,000 |
6,000 |
2.39 |
% |
|
| PFE |
Pfizer Inc |
Director |
• • – |
2023-05-05 |
4 |
B |
$38.43 |
$38,425 |
D/D |
1,000 |
5,000 |
2.39 |
% |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,232 |
3,471 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
881 |
2,239 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
963 |
1,358 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
395 |
395 |
0 |
- |
|
| PFE |
Pfizer Inc |
Director |
• • – |
2020-01-30 |
4 |
B |
$37.00 |
$36,997 |
D/D |
1,000 |
4,000 |
2.39 |
% |
|
| PFE |
Pfizer Inc |
Director |
• • – |
2019-08-23 |
4 |
B |
$34.72 |
$104,160 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2016-05-09 |
4 |
B |
$3.03 |
$12,139 |
D/D |
4,000 |
4,804 |
2.39 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2015-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,528 |
30,223 |
0 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
17,495 |
17,695 |
0 |
- |
|
|
Afh Acquisition Iii, Inc. |
Director |
– • – |
2013-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Director |
– • – |
2009-05-29 |
4 |
B |
$3.83 |
$15,320 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2009-05-28 |
4 |
B |
$7.50 |
$15,000 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
